43 employees
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
2020
$73M
from 7 investors over 7 rounds
Muna Therapeutics raised $73M on July 9, 2021
Investors: Sanofi Ventures, Sofinnova Partners, VIB, Novo Holdings, LSP (Life Sciences Partners), Polaris Partners and V-Bio Ventures